A recent paper surveys advances, challenges, and future directions for pharmaceutical 3D printing, a field with clear potential for personalized dosage forms but substantial manufacturing, regulatory, and validation hurdles.
pharmaceuticals
Dose by Design: Pharmaceutical 3D Printing and the Future of Pediatric Compounding
Charles R. Goulding and Andressa Bonafe highlight the shift from clinical pilot programs to everyday pharmacy practice, where 3D printing and R&D tax credits are reshaping the future of pediatric drug compounding.
Industry Investment is Reshaping US Research: Roche’s Expansion at Harvard and the Additive Manufacturing in Pharma
Charles R. Goulding and Aaron Rofe… reveal how overlooked incentives can quietly turn everyday operations into major savings.
University of North Carolina’s Research Strategy and 3D Printing
Charles R. Goulding and Preeti Sulibhavi examine how UNC Chapel Hill’s pragmatic research strategy, shaped by federal funding cuts and pharma reshoring, is positioning 3D printing and life-science innovation as a critical pillar of the Research Triangle’s next growth phase.
The Biotech Investment Backstop — And What It Means for 3D Printing
Charles R. Goulding and Preeti Sulibhavi demonstrate how biotech is getting a boost from stronger pharma buyers, smarter use of 3D printing, and new OBBBA tax incentives that make early-stage R&D far easier to fund.
From Lab Bench to Launchpad: Regeneron’s Bet on Tomorrow’s Innovators
Charles R. Goulding and Aaron Rofe spotlight how Regeneron’s support for young STEM talent and bold R&D spending is reshaping the frontiers of medicine and manufacturing.
Billions in the Balance: How Pharma Giants Are Betting on 3D Printing
Charles R. Goulding and Aaron Rofe reveal how industry leaders like Eli Lilly, Johnson & Johnson, and Roche are going all-in on additive manufacturing.
Dose by Design: 3D Printing, R&D Tax Credits, and the Future of Personalized Drugs
Charles R. Goulding and Preeti Sulibhavi examine how 3D printing and domestic production strategies are revolutionizing drug manufacturing and paving the way for a resilient, patient-centered pharmaceutical future.
Revolutionizing Drug Discovery: How AI and 3D Printing Are Transforming the Industry
Charles R. Goulding and Preeti Sulibhavi reveal how AI and 3D printing are revolutionizing drug discovery, highlighting trailblazers like Terray Therapeutics and Recursion Pharmaceuticals in this groundbreaking transformation.
Leading the Charge: How Eli Lilly is Revolutionizing Medicine and Manufacturing
Charles R. Goulding and Preeti Sulibhavi highlight Eli Lilly’s remarkable growth and groundbreaking advancements in pharmaceuticals, from Alzheimer’s treatment to innovative 3D printing drug delivery.
Advances in 3D Printed Drugs: Personalized Treatment and Controlled Release Mechanisms
A new research paper explores the idea of personalized 3D printed drugs.
The Intersection of Pharmaceuticals and 3D Printing: Innovations in Weight Loss Medications and Medical Devices
Charles R. Goulding and Preeti Sulibhavi examine the role of 3D printing in the context of weight loss medications.
“Pharmageddon” Opens Opportunities for 3D Printing
Charles R. Goulding and Preeti Sulibhavi examine the ongoing turmoil in the pharmaceutical industry and how 3D printing can play a role.
Book of the Week: Digital Gastronomy
This week’s selection is “Digital Gastronomy: From 3D Food Printing to Personalized Nutrition”.
Tongue Tied Pharma: Oral Thin Films And 3D Printing
Charles Goulding Jr. considers the use of 3D printing in a different sort of pharmaceutical development.
3D Printing Pills!
Purdue University’s College of Pharmacy and Aprecia Pharmaceuticals are partnering to further technology and research in pharmaceutical 3D printing.
Project Hopes To Optimize Pharmaceutical Production With 3D Printed Ceramics
The NESSIE project is attempting to optimize large scale production of pharmaceuticals by using advanced technologies, focusing on 3D printed ceramics.
3D Printing Drug Compounding Becomes More Relevant During The Coronavirus Crisis
Charles R. Goulding and Preeti Sulibhavi examine drug compounding with 3D printing technology.
Drugs, Drones, and 3D Printing
Charles Goulding and Greer Veon of R&D Tax Savers look at the use of 3D printing to promote the use of drones for retail delivery.
The Importance and Potential of 3D Printing
3D printing has the potential to transform numerous industries. From medicine to automotive, many sectors have felt the benefits of this technology and what it can do.
Book of the Week: 3D Printing of Pharmaceuticals
This week’s selection is “3D Printing of Pharmaceuticals” by Abdul W. Basit and Simon Gaisford.
Book of the Week: 3D Printing of Pharmaceuticals
This week’s selection is “3D Printing of Pharmaceuticals” by editors Abdul W. Basit and Simon Gaisford.